Baker Tilly Wealth Management, Llc
Source: SEC Form 13F · as of Mar 2026Baker Tilly Wealth Management, Llc holds 18 biotech & pharma companies tracked by BioSniper, totaling $13.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$13.2M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 10,146 | $2.5M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,188 | $1.4M |
| LLYELI LILLY & Co | 1,398 | $1.3M |
| ABBVAbbVie Inc. | 5,128 | $1.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,364 | $1.1M |
| AZNASTRAZENECA PLC | 4,468 | $881K |
| PMPhilip Morris International Inc | 4,172 | $690K |
| NVSNovartis AG | 4,227 | $646K |
| AMGNAMGEN INC | 1,486 | $523K |
| MRKMerck & Co., Inc. | 4,023 | $484K |
| GMOptec International, Inc. | 5,146 | $383K |
| IDXXIDEXX LABORATORIES INC /DE | 678 | $381K |
| GILDGILEAD SCIENCES, INC. | 2,712 | $378K |
| BMYBRISTOL MYERS SQUIBB CO | 5,524 | $335K |
| PFEPFIZER INC | 10,620 | $298K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,081 | $293K |
| NVONovo Nordisk A/S | 7,891 | $290K |
| MCKMcKesson Corporation | 294 | $254K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.